Revenue up 19.43%
United Imaging Healthcare reported revenue of RMB 10.58 billion for the first nine months of 2026, an increase of 19.43% from the same period a year earlier, the company said. Overseas revenue rose 50.30% year on year to RMB 3.00 billion.
R&D at 21.08% of revenue
R&D spending reached RMB 2.23 billion in the nine-month period, equal to 21.08% of revenue, up 0.14 percentage points year on year. The company said it employed 3,937 R&D personnel. Cumulative R&D investment from its public listing in 2022 through September 2026 amounted to RMB 10.50 billion.
Overseas growth and installations
European revenue grew nearly 30% year on year in the first nine months, while Asia-Pacific revenue more than doubled over the same period, with the company citing continued progress in Singapore, Japan, South Korea, Australia and New Zealand. Its uMR Jupiter 5T MRI system recorded first installations in Spain, Turkey and Vietnam.
Clearances and new systems
The uPMR Zenith PET/MR system received CE certification in late September. The company said it supports a 15-minute whole-body examination covering the head and neck, chest, abdomen and pelvis, cutting examination time by more than 50% against the previous generation, along with 10-minute brain imaging and regional multi-contrast MR examinations in as little as 100 seconds.
The uSONIQUE ultrasound series has approvals or clearances in China, the United States, the European Union and Singapore, and 18 ultrasound products had received FDA 510(k) clearance by the end of September. In September the company presented an ultra-low-dose digital radiography technique that, under the evaluated examination conditions, reduced radiation dose by 70%, raised image signal-to-noise ratio by 53% and increased spatial resolution by 22%. It also said it is preparing to launch uMR Prema, a zero-liquid-helium 1.5T MRI system.
